Treatment of recurrent hepatocellular carcinoma with sorafenib in a HIV/HCV Co-infected patient in HAART: A case report

Infectious Agents and Cancer

Volumn 7, Issue 1, 2012, Pages

  De Nardo, Pasquale ^a   Viscione, Magdalena ^a   Corpolongo, Angela ^a   Bellagamba, Rita ^a   Vennarecci, Giovanni ^b   Ettorre, Giuseppe Maria ^b   Gentilotti, Elisa ^a   Tommasi, Chiara ^a   Nicastri, Emanuele ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Fosamprenavir; HAART; Hepatocarcinoma; HIV HCV co infection; Sorafenib; TDM

Indexed keywords

EMTRICITABINE; FOSAMPRENAVIR; PEGINTERFERON; RIBAVIRIN; RITONAVIR; SORAFENIB; TENOFOVIR;

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHEMOEMBOLIZATION; DRUG DOSE REDUCTION; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HAND FOOT SYNDROME; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; MALE; MIXED INFECTION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84862774798     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-7-15     Document Type: Article

References (13)

1. Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness. Sulkowski M, J Hepatol 2009 50 655 658 19243854
2. Liver related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD, Arch Intern Med 2006 166 1632 1641 16908797 (Pubitemid 44232373)
3. Cirrhosis and hepatocellular carcinoma in HIV infected veterans with and without the hepatits C virus: A cohort study, 1992-2001. Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB, Arch Intern Med 2004 164 2349 2354 10.1001/archinte.164.21.2349 15557414 (Pubitemid 39532246)
4. Sorafenib in advanced hepatocellular carcinoma. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group, N Engl J Med 2008 359 378 390 10.1056/NEJMoa0708857 18650514
5. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomized, double-blind, placebo-controlled trial. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z, Lancet Oncol 2009 10 25 34 10.1016/S1470-2045(08)70285-7 19095497
6. Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co- infected patient: Possible synergy with HAART ? A case report. Chelis L, Ntinos N, Souftas V, Deftereos S, Xenidis N, Chamalidou E, Maltezos E, Kakolyris S, Med Oncol 2011 28 165 S168 10.1007/s12032-010-9669-y 20809183
7. Sorafenib Therapy for Hepatocellular Carcinoma in an HIV-HCV co-infected Patient: A Case Report. Perboni G, Costa P, Fibbia GC, Morandini B, Scalzini A, Tagliani A, Cengarle R, Aitini E, Oncologist 2010 15 142 145 10.1634/theoncologist.2010-0010 20142333
8. Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report. Ozenne V, Gervais A, Peytavin G, Castelnau C, Valla DC, Degos F, Hepatogastroenterology 2011 58 105 161 162 21510306
9. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. [ http://www.aidsinfo.nih.gov ].
10. Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis. Sherman M, Semin Liver Dis 2010 30 3 16 10.1055/s-0030-1247128 20175029
11. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. Macdonald DC, Nelson M, Bower M, Powles T, World J Gastroenterol 2008 14 11 1657 1663 10.3748/wjg.14.1657 18350596 (Pubitemid 351493371)
12. A multidisciplinary approach to the management of hepatocellular carcinoma. Gish RG, Marrero JA, Benson AB, Gastroenterol Hepatol (N Y) 2010 6 3 Suppl 6 1 16
13. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Keating GM, Santoro A, Drugs 2009 69 2 223 240 10.2165/00003495-200969020-00006 19228077